secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2022-04-04T23:59:59+00:00
Accession:  0001213900-22-017667
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Oramed Pharmaceuticals appoints Yadin Rozov to board of directors
-----------------------------------------------------------------

- Board size increased by one and Yadin Rozov appointed effective April 1, 2022.
- Rozov has over 20 years experience in capital markets, corporate finance, and investment banking.
- He is founder and managing partner of Terrace Edge Ventures LLC since January 2022.
- Rozov previously served as Partner at GoldenTree Asset Management and CEO of Syncora Guarantee.
- He will receive the same compensation as other non-executive directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390022017667/0001213900-22-017667-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390022017667/ea157933-8k_oramedphar.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-017667

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer